BUSINESS

• Genzyme Asia Pacific Senior VP to Run Japan Operations
  March 18, 2014

• Novartis Workers were Acting for Office of SIGN Trial Initiator Group: University of Tokyo
  March 17, 2014

• Bayer Yakuhin Chairman Eiki to Step Down
  March 17, 2014

• LEO Pharma to Carefully Ponder When to Begin Solo Marketing in Japan: Local Head
  March 14, 2014

• Nichi-Iko to Name Company Succeeded from Astellas “Nichi-Iko Pharma Tech”
  March 14, 2014

• Takeda to Abolish CCO Post, Commercial Operations to Come Directly Under Weber’s Control
  March 14, 2014

• Will Original Drug Makers Suddenly Embrace AGs? Comments of MHLW Official Could Spark Big Changes
  March 14, 2014

• Otsuka to Disclose Patient-Level Clinical Trial Data
  March 13, 2014

• Santen to Create New Exec Posts to Accelerate Globalization
  March 13, 2014

• Novartis Japan Sales Tick Up 0.8%, Diovan Down 13%, Tasigna Up 35%
  March 13, 2014

• Torii Confirms Positive Results from PII/III Study of Investigational Allergen Immunotherapy Treatment TO-203
  March 13, 2014

• AstraZeneca, Osaka University Aim to Resurrect Ditched Drug Candidates
  March 13, 2014

• 19 Pharmacy-Operating Companies Join Bidding Group for Drug Purchasing
  March 12, 2014

• Announcement: 7th Annual Marketing Excellence Japan 2014 – Westin Tokyo, May 13 – 14
  March 12, 2014

• Eisai to Forge Cross-Regional Biz Units for Oncology, Neurology in July
  March 11, 2014

• Otsuka, UCB Japan File Partial Change Application for Monotherapy for E Keppra
  March 11, 2014

• Ethical Drug Sales Up 4.7% in January Owing to Growth in Influenza-Related Products: Crecon Report
  March 11, 2014

• Takeda Picks Third-Party Investigator for CASE-J Issue, Probe Expected to Take 3 Months
  March 11, 2014

• Pfizer Japan Logs 1.2% Sales Increase in FY2013
  March 10, 2014

• Eisai, Biogen Idec to Jointly Develop, Commercialize AD Treatments
  March 10, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 563
• 564
• 565
• 566
• 567
• 568
• 569
• 570
• 571
• …
• Next ›
• 最終 »